引用本文:褚桂莲,罗兆莲,许晓菲,黄良胜,赵明惠.米非司酮辅助依沙吖啶羊膜腔内注射中期妊娠引产的临床观察[J].中国临床新医学,2010,3(1):54-56.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1217次   下载 878 本文二维码信息
码上扫一扫!
分享到: 微信 更多
米非司酮辅助依沙吖啶羊膜腔内注射中期妊娠引产的临床观察
褚桂莲,罗兆莲,许晓菲,黄良胜,赵明惠
535000 钦州,钦州市中医院妇产科
摘要:
[摘要] 目的 探讨米非司酮辅助依沙吖啶羊膜腔内注射终止中期妊娠临床效果。方法 随机选择88例中期妊娠者应用米非司酮辅助依沙吖啶羊膜腔内注射引产(研究组),另选67例单用依沙吖啶羊膜腔内注射引产(对照组),对两组临床情况及终止妊娠效果进行比较。结果 米非司酮辅助依沙吖啶羊膜腔内注射终止中期妊娠(研究组)的流产时间明显短于对照组,差异有统计学极显著意义(P<0.001),腔盘粘连的发生率为4.5%,明显低于对照组的22.4%,同时软产道损伤发生率及产后清宫刮出残留组织物的量也低于对照组。结论 米非司酮辅助依沙吖啶羊膜腔内注射应用于中期妊娠引产能缩短流产时间,降低胎盘粘连及软产道损伤的发生,值得推广。
关键词:  米非司酮  依沙吖啶  中期妊娠  引产
DOI:10.3969/j.issn.1674-3806.2010.01.21
分类号:R 719.3
基金项目:
Clinical observation of mifepristone combined with amniotic cavity injection of ethacridine in mid-trimester pregnancy induction delivery
ZHU Gui-Lian, LUO Zhao-Lian,XU Xiao-fei,et al.
Qinzhou Hospital of Traditional Chinese Medicine, Guangxi 535000, China
Abstract:
[Abstract] Objective To discuss the clinical effects of mifepristone combined with amniotic cavity injection of ethacridine in mid-trimester pregnancy induction delivery.Methods The pregnant women were randomly divided into two group: observation group(n=88) and control group(n=67 ), the clinical conditions of two group were compared. The observation group received mifepristone and ethacridine.The control group only received ethacridine.Results The abortion time of observation group was significantly shorter than that of control group,and the incidence of placenta adhesion was dramatly lower. At the same time,the incidence of soft birth canal injury and the volume of residues of uterine curettage was more less.Conclusion Mifepristone combined with amniotic cavity injection of ethacridine in mid-trimester pregnancy induction delivery has the adventages,such as shorter abortion time,lower the incidence of placenta adhesion and soft birth canal injury, so it is really worth to popularize.
Key words:  Mifepristone  Ethacridine  Mid-trimester pregnancy  Induction delivery